<DOC>
	<DOC>NCT00363194</DOC>
	<brief_summary>This is two-part study (Part I/Part II). Part I is designed to determine the effect of a low and high fat meal on the pharmacokinetics of single dose pazopanib (GW572016). Part II is designed to allow patients continued access to study drug in a multiple dosing regimen. Patients who are receiving clinical benefit on that regimen will go into the long term rollover study VEG105430 provided they are stable for 8 weeks.</brief_summary>
	<brief_title>A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: Confirmed advanced solid tumor(s) Must have adequate blood, liver, and kidney function. Must be willing to abstain from intercourse from 2 weeks prior to administration of the first dose of study medication until 28 days after the final dose of study medication or be willing to consistently and correctly use an acceptable method of birth control. Exclusion criteria: Patients with certain heart problems or history of bleeding within a month.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Pazopanib GW786034 Advanced cancer Metastatic cancer</keyword>
</DOC>